Alexey Danilov
Medical Director, Early Phase Therapeutics Program for the Systems Clinical Trials Office · City of Hope National Medical Center
Credentials: · · · · · · · ·
History
PresentEarly Phase Therapeutics Program for the Systems Clinical Trials Office · City of Hope National Medical Center
- 1993–1997
1997, M.D., summa cum laude, Yaroslavl Medical Academy, Russia
Research
Functional genomic landscape of acute myeloid leukaemia
Nature · 2018 · 1,111 citations
Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data
Nature Biotechnology · 2022 · 385 citations
Integrative analysis of drug response and clinical outcome in acute myeloid leukemia
Cancer Cell · 2022 · 343 citations
32 papers
- MG
23 papers · 22 as a resident
21 papers · 4 as a fellow
21 papers
21 papers
21 papers · 6 as a fellow
21 papers
- SS
21 papers
Grants
- 2024–2029
Attacking the Tumor Cell-Immune Milieu Interface to Overcome Richter's Transformation
National Cancer Institute · R01
PI · $1.4M · Columbia University Health Sciences
- 2014–2027
Phase 1 and 2 Molecular and Clinical Pharmacodynamic Trials ETCTN
National Cancer Institute · UM1
Contact PI · $5.1M · Beckman Research Institute/City of Hope
- 2021–2026
Overcoming Ibrutinib Resistance in Mantle Cell Lymphoma
National Cancer Institute · R01
Contact PI · $2.2M · Beckman Research Institute/City of Hope
Clinical trials
- 2026–2029
Principal investigator · Recruiting · Phase 2
City of Hope Medical Center
- 2025–2027
Principal investigator · Recruiting · Phase 1
City of Hope Medical Center
- 2025–2027
Nemtabrutinib With Rituximab for the Treatment of Patients With Mantle Cell Lymphoma
Principal investigator · Recruiting · Phase 2
City of Hope Medical Center
- 2023–2026
Principal investigator · Completed · Phase 2
City of Hope Medical Center